Latest Carbapenem antibiotics Stories

2014-09-08 12:29:24

Oral presentation and nine posters presented at ICAAC WASHINGTON, Sept. 8, 2014 /PRNewswire/ -- Findings reported at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) showed Shionogi's novel parenteral siderophore cephalosporin, S-694266, to exhibit marked potency against Gram-negative bacteria listed by the Centers for Disease Control and Prevention (CDC) at the urgent or serious level including multidrug-resistant Pseudomonas (MDRP),...

2014-08-19 08:29:39

DUBLIN, Aug. 19, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed positive topline results from RECLAIM-1 and -2, pivotal Phase III studies evaluating the potential for the investigational antibiotic, ceftazidime-avibactam as a treatment for adult hospitalized patients with complicated intra-abdominal infections. Logo - http://photos.prnewswire.com/prnh/20130124/NY47381LOGO Ceftazidime-avibactam consists of a cephalosporin (ceftazidime), an established treatment for...

2014-08-18 20:22:01

NEW YORK, Aug. 18, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Klebsiella Pneumoniae Infections-Pipeline Insights, 2014https://www.reportbuyer.com/product/2278616/-Klebsiella-Pneumoniae-Infections-Pipeline-Insights-2014.htmlSUMMARYDelveInsight's," Klebsiella Pneumoniae Infections-Pipeline Insights, 2014", report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding...

2013-07-19 14:38:41

Global structural properties have changed across bacterial families without putting limits on new antibiotic resistance Antibiotic-resistant bacteria have been emerging at an alarming rate. In some of the scariest of these pathogens, the mechanism responsible for the bacteria's ability to defeat antibiotics is a complex protein molecule embedded in the bacterial cell wall -- the enzyme β-lactamase. The rapid evolution of β-lactamase is the key factor responsible...

2012-02-14 00:04:28

North Carolina State University chemists have created a compound that makes existing antibiotics 16 times more effective against recently discovered antibiotic-resistant “superbugs.” These so-called superbugs are actually bacterial strains that produce an enzyme known as New Delhi metallo-β-lactamase (NDM-1). Bacteria that produce this enzyme are practically impervious to antibiotics because NDM-1renders certain antibiotics unable to bind with their bacterial targets....

2010-06-23 06:16:00

VIENNA, Austria, June 23, 2010 /PRNewswire/ -- EUCODIS Bioscience, a developer and manufacturer of customized enzymes today announced that it has launched a high-performance beta-lactamase designed to inactivate a broad range of beta-lactam antibiotics. EUCODIS Bioscience is marketing the product under the LacBuster(TM) brand. Beta-lactamases are enzymes that inactivate beta-lactam antibiotics, hydrolyzing the beta-lactam ring, a molecular structure common to these drugs. This...

Word of the Day
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.